))
Doc2Doc Podcast August 2024: Gene Therapy
Manage episode 433834992 series 3528751
Inhoud geleverd door EyeCare Partners. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door EyeCare Partners of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
This month's Doc2Doc Podcast focuses on gene therapy in eye care. Our guests are Kimberly, Drenser, M.D., Ph.D., an ophthalmologist at Associated Retinal Consultants; and Robert Sisk, M.D., FACS, an ophthalmologist at Cincinnati Eye Institute. They are featured along with hosts Albert Cheung, M.D., ophthalmologist at Virginia Eye Consultants, and Sara Lemay, OD, optometrist at Retina Associates of Kentucky.
Gene therapy in eye care is a cutting-edge approach that involves modifying or manipulating genes to potentially treat or prevent various eye diseases. This therapy holds significant promise for conditions that were previously considered untreatable or that have limited treatment options. This month's discussion includes the only currently U.S. FDA-approved gene therapy and other potential future options in the research pipeline.
24 afleveringen
Delen
